Gynecology Drugs Market at a CAGR of 5.5% from 2018 to 2030

Global Gynecology Drugs market – Snapshot

Gynecological diseases represent a collective term given to different medical conditions specific to the female reproductive system. Thus, gynecological diseases include conditions affecting the uterus, ovaries and their appendages. Gynecology drugs are the therapeutics utilized for the treatment of various gynecological diseases and symptoms. The global gynecological devices market was valued at US$ 53,376.96 Mn in 2017. It is expected to expand at a CAGR of 5.5% from 2018 to 2026.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111966

In the last decade, the adoption of gynecology drugs has increased owing to the rise in prevalence of gynecological diseases. Change in lifestyle of the global female population has gradually enhanced their healthcare requirements. Consistent rise in awareness about health and well-being has led to an increase in the demand for better gynecological treatments. Sensing this opportunity, various drug manufacturers worldwide have devised more innovative gynecology therapeutics that have better efficacy and minimum side-effects. Furthermore, rising geriatric female population and economic growth are the key factors that are likely to offer lucrative opportunity to the gynecology drugs market.

gynecology-drugs-market.jpg

The global gynecology drugs market has been segmented based on therapeutics, indication, distribution channel, and region. Furthermore, in terms of therapeutics, the market has been divided into hormonal therapy and non-hormonal therapy. The non-hormonal therapy segment is likely to account for a leading share of the global market during the forecast period owing to the effectiveness of the products, rise in adoption of these products, and new product development. Decreasing use of hormonal products due to the risk of breast cancer has boosted the demand for non-hormonal pharmaceutical products. In terms of indication, the market has been classified into gynecology cancers, endometriosis, female infertility, menopausal disorder, gynecology infections, polycystic ovary syndrome, contraception (birth control), and others. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is expected to expand at a significant CAGR during forecast period, owing to the convenience of using online pharmacy and rise in number of internet users.

In terms of region, the global gynecology drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2017, primarily due to high investments made in cutting-edge drug research, resulting in new, sophisticated treatments with specific mechanism of action; rising emphasis on cancer care, and concentration of some of the world’s major pharmaceutical and biotechnology organizations in the region. The market in Asia Pacific is anticipated to be highly attractive in the near future due to the existence of a large patient pool, increasing awareness coupled with increase in government funding, and developmental initiatives in healthcare facilities in the region. Moreover, low cost of manufacturing in China and India has resulted in the rise in production facilities, attracting key players to the region from across the world. BRICS (Brazil, Russia, India, China, and South Africa) countries are among the fastest-growing economies in the world. According to Siemens Healthineers, health care expenditure in emerging economies increased 11% from 1995 to 2012, which is expected to reach 33% by 2022. Rising population in emerging countries is likely to lead to increased demand for pharmaceutical and biopharmaceutical products in the near future.

View full report@ https://qyresearchmedical.com/report/gynecology-drugs-market-therapeutics-hormonal-therapy-non-hormonal-therapy-indication-gynecology-cancers-endometriosis-female-infertility-menopausal-disorder-gynecology-infections-polycystic-ovary-syndro-018-2030/111966

Key players operating in the global gynecology drugs market include Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Allergan Plc, and Bayer AG. These companies have diverse product offerings and extensive distribution systems across the world. Moreover, entry of small players, especially in emerging markets of Asia, is being witnessed. However, stringent regulatory framework and high-quality standards set by market leaders are anticipated to restrain the penetration of new entrants in the market.

Gynecology Drugs Market – Snapshot

In the last few years, the growth of gynecology drugs has expanded considerably because of the ascent in prevalence of gynecological diseases. Change in way of life of the worldwide female populace has gradually improved their demand for high end medical care necessities. Predictable ascent in mindfulness about wellbeing and prosperity has prompted an expansion in the interest for better gynecological medicines. Detecting this chance, different medication makers worldwide have formulated more imaginative gynecology therapeutics that have better adequacy and least results. Besides, rising geriatric female populace and monetary development are the key factors that are probably going to offer rewarding freedom to the gynecology drugs market.

Gynecologic problems influence the female reproductive system. The most common symptoms of gynecologic problems incorporate pelvic agony, vaginal tingling, vaginal release, strange vaginal dying, and bosom torment and protuberances. The importance and seriousness of these symptoms regularly rely upon age, as these symptoms might be identified with hormonal changes that happen with maturing.

Among other noticeable gynecological diseases, sexually sent illness (STD) is the most common and basic – the most common STD among women is pelvic provocative infection. In the U.S. alone, more than 1,000,000 women suffer from this issue in the course of their life, trailed by chlamydia – a sexually communicated contamination of the vagina, which, whenever left untreated, forms into pelvic incendiary illness. Gynecological problems could possibly be identified with the feminine cycle, which noticeably incorporate feminine issues and endometriosis (strangely found patches of tissue that is ordinarily found distinctly in the covering of the uterus). Moreover, gynecological cancers are additionally common among women all throughout the planet. Endometrial disease and ovarian malignant growth are profoundly common among women. Subsequently, expansion in the prevalence of the conditions referenced above, are probably going to build the take-up of gynecology drugs.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111966/2900

The global gynecology drugs market has been segmented as given below:

Therapeutics

  • Hormonal Therapy
  • Estrogen Therapy
  • Progestin Therapy
  • Combination Therapy
  • Thyroid Replacement Therapy
  • Parathyroid Hormone Therapy
  • Others
  • Non-hormonal Therapy
  • Anti-Infective Agents
  • Anti-neoplastic Agents
  • Anti-inflammatory Agents
  • Others

Indication

  • Gynecology Cancers
  • Endometriosis
  • Female Infertility
  • Menopausal Disorder
  • Gynecology Infections
  • Polycystic Ovary Syndrome
  • Contraception (Birth Control)
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Gynecology Drugs Market: Market Snapshot

4. Market Overview
4.1. Global Gynecology Drugs Market: Product Overview
4.2. Global Gynecology Drugs Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Gynecology Drugs Market Revenue Projections, 2016–2026
4.5. Porter’s Five Forces Analysis
4.6. Global Gynecology Drugs Market Outlook

5. Market Outlook
5.1. Regulatory Scenario
5.2. Disease Prevalence
5.3. Pipeline Analysis

6. Global Gynecology Drugs Market Analysis, by Therapeutics
6.1. Key Findings
6.2. Introduction
6.3. Global Gynecology Drugs Market Value Share, by Therapeutics
6.4. Global Gynecology Drugs Market Value Forecast, by Therapeutics
6.4.1. Hormonal Therapy
6.4.1.1. Estrogen Therapy
6.4.1.2. Progestin Therapy
6.4.1.3. Combination Therapy
6.4.1.4. Thyroid Replacement Therapy
6.4.1.5. Parathyroid Hormone Therapy
6.4.1.6. Others
6.4.2. Non-hormonal Therapy
6.4.2.1. Anti-Infective Agents
6.4.2.2. Anti-neoplastic Agents
6.4.2.3. Anti-inflammatory Agents
6.4.2.4. Others
6.5. Global Gynecology Drugs Market Analysis, by Therapeutics
6.6. Global Gynecology Drugs Market Attractiveness Analysis, by Therapeutics

7. Global Gynecology Drugs Market Analysis, by Indication
7.1. Key Findings
7.2. Introduction
7.3. Global Gynecology Drugs Market Value Share, by Indication
7.4. Global Gynecology Drugs Market Value Forecast, by Indication
7.4.1.1. Gynecology Cancers
7.4.1.2. Endometriosis
7.4.1.3. Female Infertility
7.4.1.4. Menopausal Disorder
7.4.1.5. Gynecology Infections
7.4.1.6. Polycystic Ovary Syndrome
7.4.1.7. Contraception (Birth Control)
7.4.1.8. Others
7.5. Global Gynecology Drugs Market Analysis, by Indication
7.6. Global Gynecology Drugs Market Attractiveness Analysis, by Indication

8. Global Gynecology Drugs Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Global Gynecology Drugs Market Value Share, by Distribution Channel
8.4. Global Gynecology Drugs Market Value Forecast, by Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.5. Global Gynecology Drugs Market Analysis, by Distribution Channel
8.6. Global Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel

9. Global Gynecology Drugs Market Analysis, by Region
9.1. Global Gynecology Drugs Market Scenario, by Country
9.2. Global Gynecology Drugs Market Value Share, by Region
9.3. Global Gynecology Drugs Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Gynecology Drugs Market Attractiveness Analysis, by Region

10. North America Gynecology Drugs Market Analysis

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111966/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi